A recent analysis shows that lung cancer mortality rate among women are projected to increase by 43% from 2015 to 2030

The global age-standardized lung cancer mortality rate among women is projected to increase by 43% from 2015 to 2030.

This is the conclusion from a recent analysis of data from 52 countries reported in Cancer Research, a peer-reviewed scientific journal published by the American Association for Cancer Research (AACR) covering research on all aspects of cancer and cancer-related biomedical sciences.[1]

The study was sponsored by the Ministry of Universities and Research of the Government of Catalonia, Spain.

The analysis also shows that the global age-standardized breast cancer mortality rate is projected to decrease by 9% in the same time frame.

?While we have made great strides in reducing breast cancer mortality globally, lung cancer mortality rates among women are on the rise worldwide,? said Jose M. Mart?nez-S?nchez, PhD, MPH, BSc, associate professor and director of the Department of Public Health, Epidemiology and Biostatistics at Universitat Internacional de Catalunya in Barcelona, Spain.

?If we do not implement measures to reduce smoking behaviors in this population, lung cancer mortality will continue to increase throughout the world,? Mart?nez-S?nchez added.

While previous work has focused on projections in lung and breast cancer mortality among women in a single country or continent, few studies have estimated trends in mortality caused by these two common cancers on a global scale, noted Mart?nez-S?nchez.

Breast and female lung cancer mortality
In this study, Mart?nez-S?nchez and colleagues analyzed breast and female lung cancer mortality data from the World Health Organization (WHO) Mortality Database from 2008 to 2014.

For inclusion in the study, countries must have reported data for at least four years between 2008 and 2014 and must have a population greater than 1 million. Fifty-two countries fulfilled these criteria: 29 from Europe; 14 from the Americas; seven from Asia; and two from Oceania.

Using a Bayesian log-linear Poisson model, lung and breast cancer age-standardized mortality rates in women, reported as per 100,000 person years, were calculated for each country based on the WHO World Standard Population, which allows for the comparison of countries with different age distributions, thereby eliminating age as a confounding variable in the projected rates.

Projected increase
Globally, among women, the mortality rate for lung cancer is projected to increase from 11.2 in 2015 to 16.0 in 2030; the highest lung cancer mortality rates in 2030 are projected in Europe and Oceania, while the lowest lung cancer mortality rates in 2030 are projected in America and Asia. Only Oceania is predicted to see a decrease in lung cancer mortality, which is projected to fall from 17.8 in 2015 to 17.6 in 2030.

?Different timelines have been observed in the tobacco epidemic across the globe,? said Mart?nez-S?nchez. ?This is because it was socially acceptable for women to smoke in the European and Oceanic countries included in our study many years before this habit was commonplace in America and Asia, which reflects why we are seeing higher lung cancer mortality rates in these countries.?

Globally, the mortality rate for breast cancer is projected to decrease from 16.1 in 2015 to 14.7 in 2030. The highest breast cancer mortality rate is predicted in Europe with a decreasing trend overall, while the lowest breast cancer mortality rate is predicted in Asia with an increasing trend overall.

Lifestyle factors
?Breast cancer is associated with many lifestyle factors,? Mart?nez-S?nchez explained. ?We are seeing an increase in breast cancer mortality in Asia because this culture is adapting a Westernized lifestyle, which often leads to obesity and increased alcohol intake, both of which can lead to breast cancer. On the other hand, we are witnessing a decrease in breast cancer mortality in Europe, which may be related to the awareness of breast cancer among this population, leading to active participation in screening programs and the improvement of treatments.?

Compared to middle-income countries, high-income countries have the highest projected age-standardized mortality rates for both lung and breast cancer in 2030. However, high-income countries are more likely to have decreasing breast cancer mortality rates. Furthermore, the first to witness lung cancer mortality rates surpass breast cancer mortality rates are mostly developed countries, noted Mart?nez-S?nchez.

?This research is particularly important because it provides evidence for health professionals and policymakers to decide on global strategies to reduce the social, economic, and health impacts of lung cancer among women in the future,? said Mart?nez-S?nchez.

Changing habits
Limitations of the study include the assumption that recent trends in lung and breast cancer mortality will continue for the next two decades. However, certain habits, such as switching from conventional cigarettes to electronic cigarettes may alter lung cancer mortality trends, Mart?nez-S?nchez said.

Future screening technology and therapeutics may lower mortality rates, he added. Additionally, due to small population size and lack of data, no countries from Africa were included in this study.

Reference
[1] Mart?n-S?nchez JC, Lunet N, Gonz?lez-Marr?n A, Lid?n-Moyano C, Matilla-Santander N, Cl?ries R, Malvezzi M, Negri E, et al.Projections in Breast and Lung Cancer Mortality among Women: A Bayesian Analysis of 52 Countries Worldwide. Cancer Res. 2018 Aug 1;78(15):4436-4442. doi: 10.1158/0008-5472.CAN-18-0187.


Last Editorial Review: August 2, 2018

Featured Image: A recent analysis shows that lung cancer mortality rate among women are projected to increase by 43% from 2015 to 2030. Courtesy: ? 2010 ? 2018 Fotolia. Used with permission.

Copyright ? 2010 ? 2018 Sunvalley Communication, LLC. All rights reserved. Republication or redistribution of Sunvalley Communication content, including by framing or similar means, is expressly prohibited without the prior written consent of Sunvalley Communication. Sunvalley Communication shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Onco?Zine, Oncozine and The Onco?Zine Brief are registered trademarks and trademarks of Sunvalley Communication around the world.